Shanghai Fudan Forward S&T Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fudan Forward S&T Co Ltd with three other
companies in this sector in China:
Ginwa Enterprise Group Inc.
sales of 727.82 million Chinese Renmimbi [US$106.17 million]
of which 52%
was Pharmaceutical Industry),
Autobio Diagnostics Co Ltd
(716.48 million Chinese Renmimbi [US$104.52 million]
Shenzhen Neptunus Interlong Bio technique Co Ltd
(721.35 million Chinese Renmimbi [US$105.23 million]
of which 63%
was Manufacturing & selling medicine product).
During the year ended December of 2015, sales at
Shanghai Fudan Forward S&T Co Ltd were 715.69 million Chinese Renmimbi (US$104.41 million).
decrease of 28.8%
versus 2014, when the company's sales were 1.01 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 42.7% decline
in Industrial, from 738.37 million Chinese Renmimbi to 422.85 million Chinese Renmimbi.
There were also decreases in sales in
Software Development (down 0.0% to 230.61 million Chinese Renmimbi)
However, these declines were partially offset by the increase in sales of
Trade (up 295.7% to 30.79 million Chinese Renmimbi)
Real Estate (up 5.9% to 21.01 million Chinese Renmimbi)
Other Operations (up 10.1% to 12.40 million Chinese Renmimbi)